ABSTRACT:
The current study aimed to assess BMP-2, P-selectin, substance-p in ß-thalassemia major patients in Babylon Province (Iraq), by enrolling individual of Arab ancestry. A total of 70 beta-thalassemia major patients and 30 normal individual were enrolled Family history. All patients were blood transfusion depend with age mean (14.1±0.7years). On the other hand the selected control do not have history of family for thalassemia and doesn’t have any disease with mean age (15.6±1.2years). The result revealed significant decrease in BMP-2 in beta-thalassemia major patients, and significant increase in P-selectin, substance P in beta-thalassemia major patients.
Cite this article:
Noor Ali Hussein, Hussein Jassim Al-Harbi. Determination the levels of Bone Morphogentic Protein-2, P-selectin, substance P in β-Thalassemia major in Iraqi patients. Research J. Pharm. and Tech. 2019; 12(6): 2677-2681. doi: 10.5958/0974-360X.2019.00447.5
Cite(Electronic):
Noor Ali Hussein, Hussein Jassim Al-Harbi. Determination the levels of Bone Morphogentic Protein-2, P-selectin, substance P in β-Thalassemia major in Iraqi patients. Research J. Pharm. and Tech. 2019; 12(6): 2677-2681. doi: 10.5958/0974-360X.2019.00447.5 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2019-12-6-10